- Home
- NSPR vs VTGN Comparison
NSPR vs VTGN Comparison
Compare NSPR & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- VTGN
- Stock Information
- Founded
- NSPR 2005
- VTGN 1998
- Country
- NSPR United States
- VTGN United States
- Employees
- NSPR N/A
- VTGN N/A
- Industry
- NSPR Medical/Dental Instruments
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- NSPR Health Care
- VTGN Health Care
- Exchange
- NSPR Nasdaq
- VTGN Nasdaq
- Market Cap
- NSPR 101.8M
- VTGN 87.2M
- IPO Year
- NSPR N/A
- VTGN N/A
- Fundamental
- Price
- NSPR $2.41
- VTGN $2.91
- Analyst Decision
- NSPR Strong Buy
- VTGN
- Analyst Count
- NSPR 2
- VTGN 0
- Target Price
- NSPR $4.50
- VTGN N/A
- AVG Volume (30 Days)
- NSPR 78.7K
- VTGN 367.0K
- Earning Date
- NSPR 11-11-2025
- VTGN 11-06-2025
- Dividend Yield
- NSPR N/A
- VTGN N/A
- EPS Growth
- NSPR N/A
- VTGN N/A
- EPS
- NSPR N/A
- VTGN N/A
- Revenue
- NSPR $7,066,000.00
- VTGN $646,000.00
- Revenue This Year
- NSPR $7.48
- VTGN $46.91
- Revenue Next Year
- NSPR $104.39
- VTGN $504.34
- P/E Ratio
- NSPR N/A
- VTGN N/A
- Revenue Growth
- NSPR 7.60
- VTGN N/A
- 52 Week Low
- NSPR $1.99
- VTGN $1.90
- 52 Week High
- NSPR $3.80
- VTGN $3.88
- Technical
- Relative Strength Index (RSI)
- NSPR 47.99
- VTGN 39.59
- Support Level
- NSPR $2.37
- VTGN $3.45
- Resistance Level
- NSPR $2.45
- VTGN $3.64
- Average True Range (ATR)
- NSPR 0.07
- VTGN 0.21
- MACD
- NSPR -0.00
- VTGN -0.07
- Stochastic Oscillator
- NSPR 37.50
- VTGN 6.73
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.